Dhanlaxmi Crop Science Ltd.
Dhanlaxmi Crop Science Ltd. (DHANLAXMI.NS) Stock Competitors & Peer Comparison
See (DHANLAXMI.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Agricultural Farm Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DHANLAXMI.NS | ₹23.20 | -5.31% | 400M | 3.74 | ₹6.55 | N/A |
| AWL.NS | ₹180.14 | -6.23% | 227.1B | 24.09 | ₹7.28 | N/A |
| GODREJAGRO.NS | ₹557.20 | -5.32% | 106.3B | 24.20 | ₹22.83 | +1.99% |
| GODREJAGRO.BO | ₹559.30 | -5.01% | 106.1B | 24.21 | ₹22.79 | +1.99% |
| AVANTI.BO | ₹433.45 | -1.17% | 75B | 16.51 | ₹26.25 | N/A |
| KSCL.NS | ₹809.20 | +5.59% | 40.4B | 13.33 | ₹58.93 | +1.27% |
| VENKEYS.NS | ₹1,255.00 | -3.85% | 17.2B | 33.72 | ₹36.28 | +0.82% |
| CHAMANSEQ.BO | ₹256.10 | +0.08% | 13.3B | 18.66 | ₹13.73 | N/A |
| ANDREWYU.NS | ₹31.70 | +1.12% | 12.7B | -150.95 | -₹0.21 | N/A |
| APEX.BO | ₹386.10 | +2.59% | 11.1B | 33.50 | ₹10.58 | +0.57% |
Stock Comparison
DHANLAXMI.NS vs AWL.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, AWL.NS has a market cap of 227.1B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while AWL.NS trades at ₹180.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas AWL.NS's P/E ratio is 24.09. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to AWL.NS's ROE of +0.10%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to AWL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check AWL.NS's competition here
DHANLAXMI.NS vs GODREJAGRO.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, GODREJAGRO.NS has a market cap of 106.3B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while GODREJAGRO.NS trades at ₹557.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas GODREJAGRO.NS's P/E ratio is 24.20. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to GODREJAGRO.NS's ROE of +0.19%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to GODREJAGRO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check GODREJAGRO.NS's competition here
DHANLAXMI.NS vs GODREJAGRO.BO Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, GODREJAGRO.BO has a market cap of 106.1B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while GODREJAGRO.BO trades at ₹559.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas GODREJAGRO.BO's P/E ratio is 24.21. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to GODREJAGRO.BO's ROE of +0.19%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to GODREJAGRO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check GODREJAGRO.BO's competition here
DHANLAXMI.NS vs AVANTI.BO Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, AVANTI.BO has a market cap of 75B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while AVANTI.BO trades at ₹433.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas AVANTI.BO's P/E ratio is 16.51. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to AVANTI.BO's ROE of N/A. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to AVANTI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check AVANTI.BO's competition here
DHANLAXMI.NS vs KSCL.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, KSCL.NS has a market cap of 40.4B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while KSCL.NS trades at ₹809.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas KSCL.NS's P/E ratio is 13.33. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to KSCL.NS's ROE of +0.19%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to KSCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check KSCL.NS's competition here
DHANLAXMI.NS vs VENKEYS.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, VENKEYS.NS has a market cap of 17.2B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while VENKEYS.NS trades at ₹1,255.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas VENKEYS.NS's P/E ratio is 33.72. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to VENKEYS.NS's ROE of +0.04%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to VENKEYS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check VENKEYS.NS's competition here
DHANLAXMI.NS vs CHAMANSEQ.BO Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, CHAMANSEQ.BO has a market cap of 13.3B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while CHAMANSEQ.BO trades at ₹256.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas CHAMANSEQ.BO's P/E ratio is 18.66. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to CHAMANSEQ.BO's ROE of +0.06%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to CHAMANSEQ.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check CHAMANSEQ.BO's competition here
DHANLAXMI.NS vs ANDREWYU.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, ANDREWYU.NS has a market cap of 12.7B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while ANDREWYU.NS trades at ₹31.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas ANDREWYU.NS's P/E ratio is -150.95. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to ANDREWYU.NS's ROE of +0.03%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to ANDREWYU.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check ANDREWYU.NS's competition here
DHANLAXMI.NS vs APEX.BO Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, APEX.BO has a market cap of 11.1B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while APEX.BO trades at ₹386.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas APEX.BO's P/E ratio is 33.50. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to APEX.BO's ROE of +0.07%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to APEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check APEX.BO's competition here
DHANLAXMI.NS vs APEX.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, APEX.NS has a market cap of 11.1B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while APEX.NS trades at ₹384.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas APEX.NS's P/E ratio is 33.48. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to APEX.NS's ROE of +0.07%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to APEX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check APEX.NS's competition here
DHANLAXMI.NS vs MAGADHSUGAR.BO Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, MAGADHSUGAR.BO has a market cap of 9.3B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while MAGADHSUGAR.BO trades at ₹657.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas MAGADHSUGAR.BO's P/E ratio is 12.00. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to MAGADHSUGAR.BO's ROE of +0.09%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to MAGADHSUGAR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check MAGADHSUGAR.BO's competition here
DHANLAXMI.NS vs ANDREWYU.BO Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, ANDREWYU.BO has a market cap of 8.7B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while ANDREWYU.BO trades at ₹17.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas ANDREWYU.BO's P/E ratio is 85.10. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to ANDREWYU.BO's ROE of +0.03%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to ANDREWYU.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check ANDREWYU.BO's competition here
DHANLAXMI.NS vs STEL.BO Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, STEL.BO has a market cap of 8B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while STEL.BO trades at ₹433.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas STEL.BO's P/E ratio is 26.92. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to STEL.BO's ROE of +0.02%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to STEL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check STEL.BO's competition here
DHANLAXMI.NS vs STEL.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, STEL.NS has a market cap of 7.9B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while STEL.NS trades at ₹432.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas STEL.NS's P/E ratio is 26.52. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to STEL.NS's ROE of +0.02%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to STEL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check STEL.NS's competition here
DHANLAXMI.NS vs DBOL.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, DBOL.NS has a market cap of 6.4B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while DBOL.NS trades at ₹96.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas DBOL.NS's P/E ratio is 26.90. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to DBOL.NS's ROE of +0.02%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to DBOL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check DBOL.NS's competition here
DHANLAXMI.NS vs DBOL.BO Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, DBOL.BO has a market cap of 6.3B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while DBOL.BO trades at ₹96.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas DBOL.BO's P/E ratio is 26.84. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to DBOL.BO's ROE of +0.02%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to DBOL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check DBOL.BO's competition here
DHANLAXMI.NS vs MGEL.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, MGEL.NS has a market cap of 3.9B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while MGEL.NS trades at ₹13.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas MGEL.NS's P/E ratio is 10.27. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to MGEL.NS's ROE of +0.18%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to MGEL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check MGEL.NS's competition here
DHANLAXMI.NS vs HARRMALAYA.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, HARRMALAYA.NS has a market cap of 3B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while HARRMALAYA.NS trades at ₹165.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas HARRMALAYA.NS's P/E ratio is 12.03. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to HARRMALAYA.NS's ROE of +0.16%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to HARRMALAYA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check HARRMALAYA.NS's competition here
DHANLAXMI.NS vs HARRMALAYA.BO Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, HARRMALAYA.BO has a market cap of 3B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while HARRMALAYA.BO trades at ₹165.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas HARRMALAYA.BO's P/E ratio is 10.54. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to HARRMALAYA.BO's ROE of +0.16%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to HARRMALAYA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check HARRMALAYA.BO's competition here
DHANLAXMI.NS vs UNITEDTEA.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, UNITEDTEA.NS has a market cap of 2.6B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while UNITEDTEA.NS trades at ₹513.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas UNITEDTEA.NS's P/E ratio is 11.54. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to UNITEDTEA.NS's ROE of +0.10%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to UNITEDTEA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check UNITEDTEA.NS's competition here
DHANLAXMI.NS vs PKTEA.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, PKTEA.NS has a market cap of 2.5B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while PKTEA.NS trades at ₹805.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas PKTEA.NS's P/E ratio is -1059.21. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to PKTEA.NS's ROE of -0.00%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to PKTEA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check PKTEA.NS's competition here
DHANLAXMI.NS vs VIKASLIFE.BO Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, VIKASLIFE.BO has a market cap of 2.3B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while VIKASLIFE.BO trades at ₹1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas VIKASLIFE.BO's P/E ratio is -15.25. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to VIKASLIFE.BO's ROE of -0.02%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to VIKASLIFE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check VIKASLIFE.BO's competition here
DHANLAXMI.NS vs JAYSREETEA.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, JAYSREETEA.NS has a market cap of 2.2B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while JAYSREETEA.NS trades at ₹78.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas JAYSREETEA.NS's P/E ratio is 5.41. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to JAYSREETEA.NS's ROE of +0.10%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to JAYSREETEA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check JAYSREETEA.NS's competition here
DHANLAXMI.NS vs JAYSREETEA.BO Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, JAYSREETEA.BO has a market cap of 2.2B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while JAYSREETEA.BO trades at ₹78.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas JAYSREETEA.BO's P/E ratio is 5.41. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to JAYSREETEA.BO's ROE of +0.10%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to JAYSREETEA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check JAYSREETEA.BO's competition here
DHANLAXMI.NS vs SAKUMA.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, SAKUMA.NS has a market cap of 2.1B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while SAKUMA.NS trades at ₹1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas SAKUMA.NS's P/E ratio is 34.00. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to SAKUMA.NS's ROE of +0.01%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to SAKUMA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check SAKUMA.NS's competition here
DHANLAXMI.NS vs SAKUMA.BO Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, SAKUMA.BO has a market cap of 2.1B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while SAKUMA.BO trades at ₹1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas SAKUMA.BO's P/E ratio is 19.43. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to SAKUMA.BO's ROE of +0.01%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to SAKUMA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check SAKUMA.BO's competition here
DHANLAXMI.NS vs ASPINWALL.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, ASPINWALL.NS has a market cap of 1.6B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while ASPINWALL.NS trades at ₹202.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas ASPINWALL.NS's P/E ratio is 17.04. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to ASPINWALL.NS's ROE of +0.05%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to ASPINWALL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check ASPINWALL.NS's competition here
DHANLAXMI.NS vs NORBTEAEXP.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, NORBTEAEXP.NS has a market cap of 1.1B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while NORBTEAEXP.NS trades at ₹90.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas NORBTEAEXP.NS's P/E ratio is -160.71. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to NORBTEAEXP.NS's ROE of -0.03%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to NORBTEAEXP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check NORBTEAEXP.NS's competition here
DHANLAXMI.NS vs NORBTEAEXP.BO Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, NORBTEAEXP.BO has a market cap of 1.1B. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while NORBTEAEXP.BO trades at ₹89.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas NORBTEAEXP.BO's P/E ratio is -156.55. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to NORBTEAEXP.BO's ROE of -0.03%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to NORBTEAEXP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check NORBTEAEXP.BO's competition here
DHANLAXMI.NS vs GROBTEA.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, GROBTEA.NS has a market cap of 983.3M. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while GROBTEA.NS trades at ₹861.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas GROBTEA.NS's P/E ratio is 17.49. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to GROBTEA.NS's ROE of +0.06%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to GROBTEA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check GROBTEA.NS's competition here
DHANLAXMI.NS vs UMAEXPORTS.BO Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, UMAEXPORTS.BO has a market cap of 672.5M. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while UMAEXPORTS.BO trades at ₹20.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas UMAEXPORTS.BO's P/E ratio is -13.81. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to UMAEXPORTS.BO's ROE of -0.02%. Regarding short-term risk, DHANLAXMI.NS is less volatile compared to UMAEXPORTS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check UMAEXPORTS.BO's competition here
DHANLAXMI.NS vs UMAEXPORTS.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, UMAEXPORTS.NS has a market cap of 663.7M. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while UMAEXPORTS.NS trades at ₹21.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas UMAEXPORTS.NS's P/E ratio is -13.63. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to UMAEXPORTS.NS's ROE of -0.02%. Regarding short-term risk, DHANLAXMI.NS is less volatile compared to UMAEXPORTS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check UMAEXPORTS.NS's competition here
DHANLAXMI.NS vs AGRITECH.BO Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, AGRITECH.BO has a market cap of 610.6M. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while AGRITECH.BO trades at ₹108.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas AGRITECH.BO's P/E ratio is -65.90. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to AGRITECH.BO's ROE of -0.01%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to AGRITECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check AGRITECH.BO's competition here
DHANLAXMI.NS vs AGRITECH.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, AGRITECH.NS has a market cap of 605.9M. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while AGRITECH.NS trades at ₹107.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas AGRITECH.NS's P/E ratio is -64.97. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to AGRITECH.NS's ROE of -0.01%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to AGRITECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check AGRITECH.NS's competition here
DHANLAXMI.NS vs KGL.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, KGL.NS has a market cap of 359.4M. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while KGL.NS trades at ₹0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas KGL.NS's P/E ratio is 1.05. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to KGL.NS's ROE of -0.67%. Regarding short-term risk, DHANLAXMI.NS is less volatile compared to KGL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check KGL.NS's competition here
DHANLAXMI.NS vs SANWARIA.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, SANWARIA.NS has a market cap of 332.9M. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while SANWARIA.NS trades at ₹0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas SANWARIA.NS's P/E ratio is -4.00. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to SANWARIA.NS's ROE of +0.01%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to SANWARIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check SANWARIA.NS's competition here
DHANLAXMI.NS vs SRPL.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, SRPL.NS has a market cap of 201.3M. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while SRPL.NS trades at ₹0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas SRPL.NS's P/E ratio is -0.50. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to SRPL.NS's ROE of -0.44%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to SRPL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check SRPL.NS's competition here
DHANLAXMI.NS vs SHANTI.NS Comparison March 2026
DHANLAXMI.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DHANLAXMI.NS stands at 400M. In comparison, SHANTI.NS has a market cap of 65M. Regarding current trading prices, DHANLAXMI.NS is priced at ₹23.20, while SHANTI.NS trades at ₹5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DHANLAXMI.NS currently has a P/E ratio of 3.74, whereas SHANTI.NS's P/E ratio is -2.33. In terms of profitability, DHANLAXMI.NS's ROE is +0.11%, compared to SHANTI.NS's ROE of +0.16%. Regarding short-term risk, DHANLAXMI.NS is more volatile compared to SHANTI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DHANLAXMI.NS.Check SHANTI.NS's competition here